Enliven Therapeutics Inc (ELVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 12-2000 | 12-1999 | 12-1998 | 12-1997 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,480 | -26,740 | -37,780 | 4,520 | -3,477 |
| Depreciation Amortization | 4,630 | 6,800 | 8,280 | 8,440 | 6,922 |
| Other Working Capital | -6,100 | 7,840 | 10,160 | -7,520 | -9,738 |
| Other Operating Activity | -210 | 1,780 | 26,090 | 480 | 4,900 |
| Operating Cash Flow | $-200 | $-10,320 | $6,750 | $5,920 | $-1,393 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,510 | -4,050 | -7,080 | -9,920 | -9,689 |
| Other Investing Activity | 4,940 | 7,490 | -5,800 | 13,030 | 4,914 |
| Investing Cash Flow | $430 | $3,440 | $-12,880 | $3,110 | $-4,775 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 130 | 1,910 | -240 | -1,120 | 339 |
| Financing Cash Flow | $130 | $1,910 | $-240 | $-1,120 | $339 |
| Beginning Cash Position | 4,210 | 9,180 | 15,550 | 7,640 | 13,475 |
| End Cash Position | 4,580 | 4,210 | 9,180 | 15,550 | 7,646 |
| Net Cash Flow | $360 | $-4,960 | $-6,360 | $7,910 | $-5,829 |
| Free Cash Flow | |||||
| Operating Cash Flow | -200 | -10,320 | 6,750 | 5,920 | -1,393 |
| Free Cash Flow | -200 | -10,320 | 6,750 | 5,920 | -1,393 |